VCX Lockup Expires Thursday: Fundrise's 100,000 Investors Can Finally Sell

TL;DR

• Fundrise's Innovation Fund (VCX) lockup expires Thursday, August 13, a month earlier than the original September 14 date. Restricted shares become tradeable Friday, August 14.
• About 100,000 retail investors hold those shares, most with a cost basis near $10-11, roughly triple the current price.
• VCX closed Wednesday at $31.89, down 94% from its $575 intraday peak on March 25, and still 68% above its $18.97 net asset value.
• Fundrise says it accelerated the unlock because the lockup had "served its primary purpose of supporting orderly price discovery." Nothing in the filing addresses what happens to supply once the shares are free.
• Two comparable venture-access vehicles, Destiny Tech100 and the Robinhood Ventures Fund, are both trading well below their own early highs. Neither is a clean precedent, but both point the same direction.

The Board

A fund that already lost 94% of its peak value still has room to fall to NAV.

What Is the VCX Lockup, and Why Does August 14 Matter?

Restricted shares in Fundrise's Innovation Fund become sellable for the first time on Friday, August 14. Fundrise listed VCX on the NYSE via direct listing on March 19, and like most direct listings it carried a standard lockup on shares issued before the debut. That lockup was supposed to run six months, expiring mid-September. On July 24, Fundrise's board moved the date a month earlier, to August 13, with an 8-K filed three days later citing "orderly price discovery" as the reason it no longer needed the extra month.

Nobody made the roughly 100,000 restricted holders sell on that date. A lockup expiration only grants permission. What it removes is the one structural reason those investors couldn't act on the price they were watching, and a lot of them have been watching a number that's fallen apart since March.

The March Mania and the Citron Crash

VCX debuted at a $18.97 net asset value and, within a week, traded as high as $575 intraday on March 25, more than 30 times NAV. The fund's pitch was straightforward: retail access to pre-IPO stakes in Anthropic, OpenAI, Databricks and a handful of other AI names that ordinary brokerage accounts can't touch. Demand outran supply almost immediately.

Andrew Left's Citron Research shorted it the next day. The report made the same point in two different ways: the stock traded over $400 against a $19 NAV, and Citron flagged a 2023 SEC settlement in which Fundrise paid $250,000 after regulators found it had "willfully" paid more than 200 influencers to promote its products without disclosure. Citron asked the SEC to look at whether that pattern was repeating with VCX.

The stock fell close to 50% intraday on the report and closed down 31% at $262 that day. It kept falling through the following sessions, and by Wednesday's close it had given back 94% of the March peak.

The Math That Still Doesn't Work

Here's the part the crash didn't fix. VCX's NAV per share was $18.97 as of March 31, on $678.9 million of net assets across 35.8 million shares outstanding. The stock closed Wednesday at $31.89. That's a 68% premium to NAV, down from a premium north of 350% back in June, but still not zero.

A fund that holds private stakes and trades on an exchange should, in theory, converge toward what those stakes are actually worth. VCX has spent five months proving that convergence isn't automatic, and I don't think Thursday's unlock changes the mechanism. What it changes is who's now allowed to act on the gap.

Who's Actually Holding the Unlocked Shares

The restricted shares came mostly from Fundrise's existing venture-fund investors, converted into VCX at listing, with a reported cost basis around $10-11 per share. At Wednesday's $31.89 close, that's close to a 3x gain for anyone who's held since before the listing, down from 7-8x at the peak but still a real profit for a retail base that, by definition, isn't used to holding illiquid venture positions.

That's the setup that makes a lockup expiration worth watching rather than a formality. A holder sitting on a tripled position with no prior way to sell has a straightforward reason to take some of it off the table, price discovery aside. Whether enough of them sell on the same days to actually move the stock is the open question, and Fundrise's filing doesn't address it.

The DXYZ Precedent, Loosely

VCX isn't the first vehicle built to sell retail investors a piece of the AI venture boom. Destiny Tech100 (DXYZ), which holds a stake in SpaceX among other private names, is down roughly 75% from its own peak. The Robinhood Ventures Fund has spent most of its life trading below its $25 debut price. Neither fund had an accelerated lockup event quite like SpaceX's staggered unlock calendar, so the comparison is directional, not a forecast. What both funds share with VCX is the same structural flaw: a closed pool of shares trading at whatever premium enthusiasm will support, with no arbitrage mechanism to force the price back to NAV until something, in VCX's case a lockup, changes the supply.

I'd put more weight on the SpaceX comparison from our own coverage of SPCX's unlock: that stock's 911.5-million-share release didn't produce the crash the market was pricing, because eligible holders weren't forced sellers and the fear had already been charged into the price on the way down. VCX has fallen 94% into this one, so some of that fear is probably priced already. It hasn't fallen to NAV, so the premium that Citron flagged in March is still sitting there, smaller but unresolved.

The Options Angle

VCX has a listed options chain, but I couldn't source live quotes for it: strikes, bid-ask spreads and open interest sit behind subscription paywalls on the venues that carry them. A stock five months off a direct listing with this kind of price history is a bad candidate for trusting a stale quote anyway.

Pass, on the whole setup. The lockup itself resolves nothing about whether VCX converges toward NAV or stays elevated on illiquidity; it just adds the people most likely to sell into the pool of people who can. I'm not structuring a view around a data point I don't have a priced way to express. If the stock is still trading at a large premium to NAV a week from now with unlock volume behind it, that premium becomes the more interesting short thesis than anything struck against Thursday's date itself.

Trade log

#	Stance	Structure	Strikes and expiry	Cost or credit	Spot at writing	Implied move	Breakeven
1	Pass	Any options structure into the unlock	n/a	Live chain not sourced	$31.89, Wed Aug 12 close	not sourced	n/a, logged as a pass to be scored

The One-Line Read

VCX lost 94% of its peak value before its lockup even expired, and it's still 68% above what its assets are actually worth; Thursday hands the people most likely to close that gap their first chance to sell.